By Jo Stephenson2012-07-27T12:36:00
 
      Advances in safeguarding patients that came out of the Shipman inquiry must not be lost amid NHS reforms, says a report on the management of controlled drugs.
 
	With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. 5th Floor, Aldgate Tower, 2 Leman Street, London E1 8FA. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud
 
